Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2.

ABSTRACT: Recent pandemic situation of COVID-19 is caused due to SARS-CoV2 and almost all the countries of the world have been affected by this highly contagious virus. Main protease (M^pro) of this virus is a highly attractive drug target among various other enzymes due to its ability to process poly-protein that is the translated product of the SARS-CoV2 RNA. The present study demonstrates molecular docking study of Glycyrrhiza glabra (Gg) active compounds such as Glycyrrhizic acid (GA), Liquiritigenin (L) and Glabridin (G) against the M^pro. Docking studies shows that these active compounds bind strongly with some of the amino acid residues in the active site of M^pro and inhibits the enzyme strongly. GA, L, and G are proposed to be strong inhibitors of the en

SUBMITTER: Srivastava V 

PROVIDER: S-EPMC7556787 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature